泰達生物(08189.HK)委任範陳會計師行為新任核數師
格隆匯12月20日丨泰達生物(08189.HK)公吿,由於香港立信德豪會計師事務所有限公司與公司未能就截至2021年12月31日止年度的審計費用達成共識,故香港立信德豪已提請辭任公司核數師;根據審核委員會的推薦建議,董事會已決議建議委任範陳會計師行有限公司為公司新任核數師,自2021年12月20日起生效。
公司獨立監事馮玲女士由於其他事務繁忙,致使彼不再有充裕時間投身於公司業務,故已提呈書面通知辭任公司獨立監事職位。根據公司章程及監事會提名,建議選舉趙志友先生為第七屆監事會獨立監事候選人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.